Ropes & Gray Leads Pfizer In Deal For AstraZeneca Unit
Pfizer, led by Ropes & Gray, will snap up AstraZeneca's small molecule anti-infectives unit, the U.S. pharmaceutical giant said Wednesday, just two days after unveiling a $14 billion buyout of oncology...To view the full article, register now.
Already a subscriber? Click here to view full article